Etamsylate Injection
- Packing: 2 Ml Ampoule.
- Available Strength : 125 Mg/Ml
Description
Product Description: Etamsylate Injection is a sterile solution containing etamsylate, a hemostatic agent that promotes clot formation and controls bleeding. It is indicated for the prevention and treatment of hemorrhagic conditions associated with various medical and surgical procedures.
Indications and Usage: Etamsylate Injection is used to manage bleeding associated with a variety of conditions, including menorrhagia (heavy menstrual bleeding), postpartum hemorrhage, dental extractions, surgical procedures, and traumatic injuries. It is also employed to reduce bleeding during invasive diagnostic or therapeutic interventions.
Dosage and Administration: The dosage of Etamsylate Injection varies depending on the severity of bleeding and the patient's response to treatment. It is typically administered intravenously or intramuscularly. The initial dose and frequency of administration should be determined by a healthcare professional based on the specific clinical situation.
Dosage Forms and Strengths: Etamsylate Injection is available as a sterile solution in vials for intravenous or intramuscular injection. It is commonly supplied in various strengths, typically ranging from 125 mg/mL to 250 mg/mL.
Contraindications: Etamsylate Injection is contraindicated in patients with a known hypersensitivity to etamsylate or any component of the formulation. It should not be used in individuals with thromboembolic disorders or a history of arterial or venous thrombosis.
Warnings and Precautions: Use caution when administering Etamsylate Injection to patients with renal impairment or a history of peptic ulcer disease. Monitor patients closely for signs of hypersensitivity reactions, thromboembolic events, or gastrointestinal bleeding during therapy.
Adverse Reactions/Side Effects: Common adverse reactions associated with Etamsylate Injection may include gastrointestinal upset, headache, dizziness, and skin rash. Rarely, severe allergic reactions or thromboembolic events such as deep vein thrombosis or pulmonary embolism may occur.
Drug Interactions: There are no known significant drug interactions with Etamsylate Injection. However, it may potentiate the effects of anticoagulant medications or other drugs that affect platelet function. Use caution when administering concurrently with such agents.
Use In Specific Populations Description: Safety and efficacy of Etamsylate Injection in pediatric patients, pregnant women, and nursing mothers have not been established. Use caution and consult with a healthcare professional before administering to individuals in these populations.
How Supplied/Storage and Handling: Etamsylate Injection is supplied as a sterile solution in vials for intravenous or intramuscular administration. It should be stored at controlled room temperature (20°C to 25°C) away from light and moisture. Care should be taken to ensure proper storage and handling to maintain the integrity of the product. Unused portions should be discarded according to standard procedures for biohazardous waste.